Kathryn Litten, PharmD, joined Drug Topics to discuss how pharmacists can counsel patients with metabolic dysfunction-associated steatotic liver disease.
Ashley Gallagher, MA
Advertisement
Ashley Gallagher is an assistant managing editor at Drug Topics®. She graduated in 2020 in journalism and mass communications and received her master’s degree in 2025 in digital journalism from St. Bonaventure University. Previously, she worked as a pharmacy technician for a retail chain.
Articles by Ashley Gallagher, MA
A discussion with Kevin Cowart, PharmD, MPH, BCACP, FCCP, BCPS, assistant professor at the University of South Florida Taneja College of Pharmacy.
John Bucheit, PharmD, discussed lipid-lowering medications and how nonstatins can be beneficial for cardiovascular health.
A discussion with Brittany Norton, PharmD, director of ambulatory care at Sutter Health.
Paying for these new therapies, that may be curative for patients, remains a challenge.
Advertisement
Advertisement
Advertisement
Trending on Drug Topics
1
FAQ: The Medicare GLP-1 Bridge—What Independent Pharmacists Need to Know
2
Strategies to Drive Pharmacy Sustainability in a Changing Landscape
3
Grocery Pharmacy Conglomerate to Pay $40 Million for Violating False Claims Act
4
Machine Learning Can Identify Immune Markers for Better Pneumococcal Vaccines
5